Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Philemon Papanastasiou"'
Autor:
Alice B. Gottlieb, Atul Deodhar, Iain B. Mcinnes, Xenofon Baraliakos, Kristian Reich, Stefan Schreiber, Weibin Bao, Kwaku Marfo, Hanno B. Richards, Luminita Pricop, Abhijit Shete, Vivek Trivedi, Deborah Keefe, Charis C. Papavassilis, Piotr Jagiello, Philemon Papanastasiou, Philip J. Mease, Mark Lebwohl
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Secukinumab, a selective interleukin (IL)-17A inhibitor, is approved for use in adult and paediatric psoriasis, psoriatic arthritis, ankylosing spondylitis and non-radiographic axial spondyloarthritis. The aim of this study was to report the long-ter
Externí odkaz:
https://doaj.org/article/df7f9d86b24a460b8b32d03dd5d1cb7c
Autor:
Nina, Magnolo, Külli, Kingo, Vivian, Laquer, John, Browning, Adam, Reich, Jacek C, Szepietowski, Deborah, Keefe, Philemon, Papanastasiou, Weibin, Bao, Pascal, Forrer, Manmath, Patekar
Publikováno v:
Pediatric Drugs. 24:377-387
The efficacy and safety of biologic treatments for children and adolescents with moderate to severe psoriasis should be examined over a considerable time period and in different subgroups.We report the efficacy and safety of secukinumab low dose (LD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb54555b127e89d132c8de9db7be2a3c
https://doi.org/10.1007/s40272-022-00507-0
https://doi.org/10.1007/s40272-022-00507-0
Autor:
Enrique Rivas, Külli Kingo, Manmath Patekar, Christine Bodemer, Andrzej Kaszuba, Akimichi Morita, Charis Papavassilis, Gerard Bruin, Philemon Papanastasiou, R. You, Athanasios Tsianakas
Publikováno v:
Journal of the American Academy of Dermatology. 85:AB59
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30c032e36a2939c334a0b0feb9451445
https://doi.org/10.1016/j.jaad.2021.06.263
https://doi.org/10.1016/j.jaad.2021.06.263
Autor:
Andrzej Kaszuba, Deborah L. Keefe, Lixin Zhang, Athanasios Tsianakas, Philemon Papanastasiou, Linda Ann Wraith, Manmath Patekar
Publikováno v:
Journal of the American Academy of Dermatology. 83:AB133
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f78059265391e9fcad1513c5550b159
https://doi.org/10.1016/j.jaad.2020.06.620
https://doi.org/10.1016/j.jaad.2020.06.620
Autor:
Alice B, Gottlieb, Andrew, Blauvelt, Jörg C, Prinz, Philemon, Papanastasiou, Rashidkhan, Pathan, Judit, Nyirady, Todd, Fox, Charis, Papavassilis
Publikováno v:
Journal of drugs in dermatology : JDD. 15(10)
Secukinumab, a human monoclonal antibody that selectively targets interleukin-17A, is highly efficacious in the treatment of moderate-to-severe psoriasis, starting at early time points, with a sustained effect and a favorable safety profile.Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d0ed8e90d674ec9113b9fe31e10227f0
https://pubmed.ncbi.nlm.nih.gov/27741340
https://pubmed.ncbi.nlm.nih.gov/27741340
Autor:
David M. Reid, C. Roux, Kenneth G. Saag, J-Y Reginster, Philip N. Sambrook, Christina Bucci-Rechtweg, Chak Sing Lau, Jean-Pierre Devogelaer, Guoqin Su, Philemon Papanastasiou
Publikováno v:
Osteoporosis International. 23:1083-1090
This study summarizes the treatment effect of zoledronic acid infusion on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis. Zoledronic acid is significantly more effective than risedronate in increasin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2428e44b0ab8417650452aad3c8012cb
https://doi.org/10.1007/s00198-011-1800-1
https://doi.org/10.1007/s00198-011-1800-1
Autor:
Paul D. Miller, Christina Bucci-Rechtweg, Erik Fink Eriksen, Felicia Cosman, Steven Boonen, Núria Guañabens, Philemon Papanastasiou, Hanumantha Rao, Chris Recknor, Christian Kasperk, Aimee Readie, Jürg A. Gasser
Publikováno v:
Journal of Bone and Mineral Research. 26:503-511
Clinical data suggest concomitant therapy with bisphosphonates and parathyroid hormone (PTH) may blunt the anabolic effect of PTH; rodent models suggest that infrequently administered bisphosphonates may interact differently. To evaluate the effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9de181a1e500cac9b734d84bdde72254
https://doi.org/10.1002/jbmr.238
https://doi.org/10.1002/jbmr.238
Autor:
Christian Roux, Philemon Papanastasiou, Jean-Yves Reginster, F. Hartl, Philip N. Sambrook, Kenneth G. Saag, Peter Mesenbrink, Chak Sing Lau, David M. Reid, Alberto Ferreira, T. Fashola, Jean-Pierre Devogelaer
Publikováno v:
Obstetrical & Gynecological Survey. 64:521-523
Compliance and adherence with oral daily and weekly bisphosphonate therapy is generally poor in postmenopausal women at increased risk of glucocorticoid-induced osteoporosis. Previous studies have shown that a single yearly intravenous dose of zoledr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7ec98df13ee9fdf015ea490349bea06
https://doi.org/10.1097/01.ogx.0000356937.03800.0f
https://doi.org/10.1097/01.ogx.0000356937.03800.0f
Publikováno v:
Molecular and Biochemical Parasitology. 86:13-27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4487f2512ec0138661c579b8201710d3
https://doi.org/10.1016/s0166-6851(97)02836-3
https://doi.org/10.1016/s0166-6851(97)02836-3
Publikováno v:
Molecular and Biochemical Parasitology. 86:13-27
Trophozoites of Giardia duodenalis express at their cell surface variant-specific proteins (VSPs) that are believed to contribute to the protection of the parasite from immunological and other host defense mechanisms. In the present study, we have cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9edc3bfebaaa9bf61c89ab4c597a1432
https://doi.org/10.1016/s0166-6851(97)90002-5
https://doi.org/10.1016/s0166-6851(97)90002-5